Inactive Instrument

IMCLONE SYSTEMS Share Price Nasdaq

Stocks

End-of-day quote Nasdaq
- ^USD	-

29/11/-1	IMCLONE SYSTEMS : Lilly bids $6.5 billion for ImClone	RE
29/11/-1	IMCLONE SYSTEMS : Lilly to acquire ImClone Systems in $6.5 billion transaction	RE

29/11/-1	IMCLONE SYSTEMS : Lilly bids $6.5 billion for ImClone	RE
29/11/-1	IMCLONE SYSTEMS : Lilly to acquire ImClone Systems in $6.5 billion transaction	RE
29/11/-1	IMCLONE SYSTEMS : ImClone set to be acquired by Eli Lilly: sources	RE
29/11/-1	IMCLONE SYSTEMS : ImClone set to be acquired by Eli Lilly for $6.1 bln: sources	RE
29/11/-1	IMCLONE SYSTEMS : ImClone to announce sale talks continuing: report	RE
29/11/-1	IMCLONE SYSTEMS : ImClone says it received $70-a-share buyout offer	RE
29/11/-1	IMCLONE SYSTEMS : ImClone says has received $70 share buyout offer	RE
29/11/-1	IMCLONE SYSTEMS : ImClone says hires JP Morgan to weigh options	RE
29/11/-1	IMCLONE SYSTEMS : ImClone hires JP Morgan to weigh options: sources	RE
29/11/-1	IMCLONE SYSTEMS : ImClone calls Bristol offer too low	RE
29/11/-1	IMCLONE SYSTEMS : ImClone to study Bristol offer	RE
29/11/-1	IMCLONE SYSTEMS : Lilly profit falls on ImClone charges	RE
29/11/-1	IMCLONE SYSTEMS : Lilly says 2009 earnings crimped by ImClone costs	RE

29/11/-1	IMCLONE SYSTEMS : Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share	PR
29/11/-1	IMCLONE SYSTEMS : Icahn Responds to Cornelius	PR
29/11/-1	Imclone Systems : Seven Summits Research Releases Comments on QCOM, NOK, BUD, COF, and IMCL	PR
29/11/-1	Imclone Systems : ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property	BU
29/11/-1	Imclone Systems : ImClone Systems to Present at the Bear Stearns Annual Healthcare Conference	BU

29/11/-1	ImClone : accord de rachat par Eli Lilly pour 6,5 Mds$.
29/11/-1	ImClone : un groupe pourrait faire une proposition de rachat.
29/11/-1	ImClone : début de la vente de l'Erbitux au Japon.
29/11/-1	ImClone Systems : rejette l'offre de Bristol-Myers Squibb.
29/11/-1	ImClone : recrute des patients pour des tests cliniques.

Employees

Sector